Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, issue.5795, pp.1960-1964, 2006. ,
DOI : 10.1126/science.1129139
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma, Journal of Clinical Investigation, vol.120, issue.6, pp.2030-2039, 2010. ,
DOI : 10.1172/JCI42002DS1
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy, Clinical Cancer Research, vol.17, issue.13, pp.4550-4557, 2011. ,
DOI : 10.1158/1078-0432.CCR-11-0116
Chimeric Antigen Receptor???Modified T Cells for Acute Lymphoid Leukemia, New England Journal of Medicine, vol.368, issue.16, pp.1509-1518, 2013. ,
DOI : 10.1056/NEJMoa1215134
Revisiting the role of T cells in tumor regression, OncoImmunology, vol.79, issue.3, pp.346-350, 2012. ,
DOI : 10.1002/ijc.24961
Dr William Coley and tumour regression: a place in history or in the future, Postgrad Med J, vol.79, pp.672-80, 2003. ,
In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor, The Journal of Experimental Medicine, vol.115, issue.2, pp.345-356, 2007. ,
DOI : 10.1084/jem.20041378
Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice, Journal of Clinical Investigation, vol.118, issue.4, pp.1390-1397, 2008. ,
DOI : 10.1172/JCI34388
The Rate of the CD8-Dependent Initial Reduction in Tumor Volume Is Not Limited by Contact-Dependent Perforin, Fas Ligand, or TNF-Mediated Cytolysis, The Journal of Immunology, vol.173, issue.3, pp.1738-1781, 2004. ,
DOI : 10.4049/jimmunol.173.3.1738
Differential requirement of perforin and IFN-?? in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen, European Journal of Immunology, vol.30, issue.9, pp.2507-2522, 2000. ,
DOI : 10.1002/1521-4141(200009)30:9<2507::AID-IMMU2507>3.0.CO;2-V
Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors, Journal of Clinical Investigation, vol.122, issue.3, pp.899-910, 2012. ,
DOI : 10.1172/JCI45817DS1
Random migration precedes stable target cell interactions of tumor-infiltrating T cells, The Journal of Experimental Medicine, vol.70, issue.12, pp.2749-2761, 2006. ,
DOI : 10.3109/10739689609148303
CD8+ Tumor-Infiltrating T Cells Are Trapped in the Tumor-Dendritic Cell Network, Neoplasia, vol.15, issue.1, p.85, 2013. ,
DOI : 10.1593/neo.121572
Marginating Dendritic Cells of the Tumor Microenvironment Cross-Present Tumor Antigens and Stably Engage Tumor-Specific T Cells, Cancer Cell, vol.21, issue.3, pp.402-417, 2012. ,
DOI : 10.1016/j.ccr.2012.01.008
The Shiga toxin B-subunit targets antigenin vivo to dendritic cells and elicits anti-tumor immunity, European Journal of Immunology, vol.145, issue.5, pp.1124-1135, 2006. ,
DOI : 10.1002/eji.200535443
CCR7 ligands control basal T cell motility within lymph node slices in a phosphoinositide 3???kinase??? independent manner, The Journal of Experimental Medicine, vol.159, issue.5, pp.1167-1179, 2007. ,
DOI : 10.4049/jimmunol.173.1.50
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy, Cancer Discovery, vol.1, issue.1, pp.54-67, 2011. ,
DOI : 10.1158/2159-8274.CD-10-0028
Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization, International Journal of Cancer, vol.13, issue.2, pp.335-345, 2006. ,
DOI : 10.1002/ijc.21371
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation, Immunity, vol.40, issue.2, pp.274-288, 2014. ,
DOI : 10.1016/j.immuni.2014.01.006
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy, The Journal of Experimental Medicine, vol.112, issue.6, p.727, 2001. ,
DOI : 10.1038/sj.onc.1201869
Trophic macrophages in development and disease, Nature Reviews Immunology, vol.87, issue.4, pp.259-270, 2009. ,
DOI : 10.1038/nri2528
Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors, Proc. Natl. Acad. Sci, pp.2066-2071, 2012. ,
DOI : 10.1073/pnas.1113099109
Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy, Cancer Cell, vol.24, issue.5, pp.589-602, 2013. ,
DOI : 10.1016/j.ccr.2013.09.014
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans, CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans, pp.1612-1616, 2011. ,
DOI : 10.1126/science.1198443
Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages, Immunology, vol.181, issue.2, pp.226-239, 2011. ,
DOI : 10.1111/j.1365-2567.2010.03357.x
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer, Nature Communications, vol.65, p.240, 2011. ,
DOI : 10.1093/jnci/80.17.1393
CTL Induction of Tumoricidal Nitric Oxide Production by Intratumoral Macrophages Is Critical for Tumor Elimination, The Journal of Immunology, vol.185, issue.11, pp.6706-6718, 1950. ,
DOI : 10.4049/jimmunol.0903411
IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression, Cancer Research, vol.71, issue.17, pp.5697-5706, 2011. ,
DOI : 10.1158/0008-5472.CAN-11-0103
The role of type I interferons in non-viral infections, Immunological Reviews, vol.52, issue.1, pp.33-48, 2004. ,
DOI : 10.1038/nm0897-849
Direct effects of type I interferons on cells of the immune system, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.17, pp.2619-2627, 2011. ,
Cancer cell???autonomous contribution of type I interferon signaling to the efficacy of chemotherapy, Nature Medicine, vol.8, issue.11, pp.1301-1309, 2014. ,
DOI : 10.1038/nm.3708
Identification and manipulation of tumor associated macrophages in human cancers, Journal of Translational Medicine, vol.9, issue.1, p.216, 2011. ,
DOI : 10.1186/1479-5876-9-216
IFN-?? Regulates Donor CD8 T Cell Expansion, Migration, and Leads to Apoptosis of Cells of a Solid Tumor, The Journal of Immunology, vol.177, issue.5, pp.3004-3011, 2006. ,
DOI : 10.4049/jimmunol.177.5.3004
Efficacy of CAR T-cell Therapy in Large Tumors Relies upon Stromal Targeting by IFN??, Cancer Research, vol.74, issue.23, pp.6796-6805, 2014. ,
DOI : 10.1158/0008-5472.CAN-14-0079
B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity, J. Immunol. Baltim. Md, vol.179, pp.3371-3379, 1950. ,
URL : https://hal.archives-ouvertes.fr/hal-00172517
Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors, Science Translational Medicine, vol.5, issue.172, pp.172-192, 2013. ,
DOI : 10.1126/scitranslmed.3004888
Recruitment of monocytes/macrophages in different tumor microenvironments, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1835, issue.2, pp.170-179, 2013. ,
DOI : 10.1016/j.bbcan.2012.12.007
Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy, Disease Models and Mechanisms, vol.1, issue.2-3, pp.155-167, 2008. ,
DOI : 10.1242/dmm.000596
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis, Nature, vol.64, issue.7355, pp.222-225, 2011. ,
DOI : 10.1038/nature10138
TNF/iNOS-Producing Dendritic Cells Mediate Innate Immune Defense against Bacterial Infection, Immunity, vol.19, issue.1, pp.59-70, 2003. ,
DOI : 10.1016/S1074-7613(03)00171-7
CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy, Cancer Research, vol.74, issue.2, pp.436-445, 2014. ,
DOI : 10.1158/0008-5472.CAN-13-1265
Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-alpha, Immunology, vol.174, issue.2, pp.261-270, 2006. ,
DOI : 10.1007/s00262-003-0443-2
Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells, Proc. Natl. Acad. Sci, pp.13085-13090, 2013. ,
DOI : 10.1073/pnas.1300314110
Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy, Cancer Research, vol.74, issue.1, pp.153-161, 2014. ,
DOI : 10.1158/0008-5472.CAN-13-1816
Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy, PLoS ONE, vol.8, issue.8, p.104230, 2014. ,
DOI : 10.1371/journal.pone.0104230.g005
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon, Nature Immunology, vol.4, issue.10, pp.1009-1015, 2003. ,
DOI : 10.1038/ni978
Peripheral Prepositioning and Local CXCL9 Chemokine-Mediated Guidance Orchestrate Rapid Memory CD8+ T Cell Responses in the Lymph Node, Immunity, vol.38, issue.3, pp.502-513, 2013. ,
DOI : 10.1016/j.immuni.2012.11.012
Early T Cell Signalling Is Reversibly Altered in PD-1+ T Lymphocytes Infiltrating Human Tumors, PLoS ONE, vol.204, issue.3, p.17621, 2011. ,
DOI : 10.1371/journal.pone.0017621.s006